Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 59 results found. Search for [ Chinese vaccine candidates ]

Results 1 to 21 of 59
BusinessToday.In
September 16, 2020
Coronavirus vaccine trials: While China has four vaccine candidates in third or final stages of clinical trials, there are at least two companies from the United States and one from UK and Germany, which are planning to rollout vaccine before December, if everything goes as per the plan


Joe C Mathew
September 14, 2020
Stating that an effective vaccine would be the sure shot tool in containing COVID-19, Dr Vardhan said more than 30 vaccine candidates are in different stages of development in India


Reuters
September 3, 2020
COVAX is co-led by GAVI, the WHO and the Coalition for Epidemic Preparedness Innovations (CEPI), and is designed to discourage national governments from hoarding COVID-19 vaccines and to focus on first vaccinating the most high-risk people in every country


PTI
August 28, 2020
In a blistering speech hours before Trump was to the deliver his acceptance speech to the Republican National Convention, Harris alleged that the president's policies have been a reckless disregard for the danger a pandemic would pose to American lives


PTI
August 24, 2020
One month has passed since China officially launched the urgent use of COVID-19 vaccines on July 22, while the vaccines were going through clinical trials


BusinessToday.In
August 17, 2020
Coronavirus vaccine news update: Russia has produced the first batch of COVID-19 vaccine, Sputnik V, the health ministry said. The country said that the vaccine will be rolled out by end of month


BusinessToday.In
August 17, 2020
Last month, the medical journal Lancet wrote that the Phase-2 clinical trial of CanSino Biologics' adenovirus vector vaccine or Ad5-nCoV was safe and induced immune response


BusinessToday.In
August 9, 2020
Coronavirus vaccine update: However, the clinical trial data and other documents of Russia's COVID-19 vaccine are currently under expert review. The decision on registration will be made based on its results


Reuters
August 5, 2020
Brazil's federal government has said it will invest 1.9 billion reais ($355 million) to process and produce the AstraZeneca vaccine


BusinessToday.In
July 27, 2020
Of the total vaccine candidates, 140 are at the pre-clinical stage, while 19 have entered phase 1. A total of 13 vaccines have entered in expanded safety trials of Phase 2, while four vaccine candidates are undergoing large-scale efficacy trials in Phase 3


Reuters
July 24, 2020
ARCoV is a messenger RNA vaccine which uses technology similar to candidates being developed by Moderna and BioNtech and Pfizer. It is the second potential COVID-19 vaccine that China's military-backed research unit has moved into clinical trials


BusinessToday.In
July 24, 2020
Coronavirus (Covid-19) Vaccine News Latest Updates:  The study showed that curcumin can prevent Transmissible gastroenteritis virus (TGEV)- an alpha-group coronavirus that infects pigs, from infecting cells. The higher doses of curcumin were also found to kill virus particles


BusinessToday.In
July 23, 2020
Coronavirus (Covid-19) Vaccine News Latest Updates: Head of WHO's emergencies programme Mike Ryan has said that while there are multiple contenders and many companies have made significant progress, the likely time for a coronavirus vaccine in the market is not before 2021


BusinessToday.In
July 22, 2020
Coronavirus (COVID-19) Vaccine News Latest Updates: Dr Cyrus Poonawalla, Chairman of the Poonawalla Group, says a just a few million doses of the potential COVID-19 vaccine will not be enough and the company intends to manufacture around 1 billion doses after getting all the necessary approvals


Chitranjan Kumar
July 21, 2020
Share market updates and analysis for July 22: Corporate earnings announcements, coronavirus vaccine hopes and global cues to set tone for stock markets


Associated Press
July 21, 2020
We now need to move into larger-scale real-world trials, Dr Michael Ryan told reporters at a news conference in Geneva


BusinessToday.In
July 20, 2020
Hyderabad-based Bharat Bharat Biotech India (BBIL) in collaboration with ICMR's National Institute of Virology (NIV) has developed India's first indigenous COVID-19 vaccine candidate Covaxin


BusinessToday.In
New Delhi, July 16, 2020
Google to invest Rs 33,737 crore in Jio PlatformsMukesh Ambani, during the Reliance Industries Annual General Meeting on Wednesday announced that Google would invest Rs 33,737 crore in Jio Platforms. Google is the latest tech giant to invest in Jio Platforms after Facebook, Qualcomm and Intel. Google's is the 14th investment since April 22 amounting to a total of Rs 152,055.45 crore.Decision on Tiktok, Chinese apps likely in weeks, not months: White HouseThe White House indicated on Wednes...


BusinessToday.In
July 8, 2020
Coronavirus vaccine update: Twelve hospitals have been chosen for COVAXIN trials in the country. Bharat Biotech's COVAXIN is undergoing quality and safety tests before the doses are administered to volunteers


BusinessToday.In
July 6, 2020
Coronavirus vaccine: AIIMS in Delhi and Patna are among the 12 institutes selected to conduct the clinical trials for Covaxin


PAGES 1 OF 3  123